Global biotechnology leader CSL (CSL; USOTC:CSLLY (OTC:CSLLY)) and Arcturus Therapeutics (NASDAQ:ARCT) today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) granted...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease...
Arcturus Therapeutics (NASDAQ:ARCT) provided an update on its Q3 2023 performance and ongoing projects during its recent earnings call. The company's monovalent COVID-19 vaccine, ARCT-154,...
An analyst from Citi maintained Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) at 'buy' with a price target of $40.00 from a prior price target of $35.00. Prior to this rating, Arcturus...
After-Hours Stock Movers:Arcturus Therapeutics (NASDAQ:ARCT) 14% HIGHER; reported Q3 EPS of ($0.61), $1.01 better than the analyst estimate of ($1.62). Revenue for the quarter came in at...
Investing.com - Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) reported third quarter EPS of $-0.61, $1.01 better than the analyst estimate of $-1.62. Revenue for the quarter came in at...
LANHAM, Md., Oct. 25, 2023 (GLOBE NEWSWIRE) -- October is ADHD Awareness Month, and CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder)―the leading resource for...
Interestingly, there was no increased risk of dementia in adults with ADHD who took stimulants, like Adderall or Concerta, to manage the condition.
The defense team is nearing crunch time.
Access to information sounds like a positive thing. However, too much information in a short span of time is not quite that. We live in a time where trying to get information has never been...
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities...
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities...
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities...
Arcturus Therapeutics (NASDAQ:ARCT) Holdings Inc. (Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and...
Investing.com - Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) reported second quarter EPS of $-1.98, $1.30 worse than the analyst estimate of $-0.68. Revenue for the quarter came in at...
An analyst from William Blair initiated coverage of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) at 'outperform' . Prior to this rating, Arcturus Therapeutics Holdings Inc had 6 buy...
Arcturus Therapeutics (NASDAQ:ARCT) Holdings Inc. (Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and...
By Davit KirakosyanInvesting.com -- Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades for |Albemarle, Euronav, Arcturus Therapeutics, and Palo...
An analyst from H.C. Wainwright upgraded Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) from '' 'buy' with a price target of $51.00. Prior to this rating, Arcturus Therapeutics Holdings...
Investing.com - Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) reported first quarter EPS of $1.87, $1.81 better than the analyst estimate of $0.06. Revenue for the quarter came in at...
By Davit Kirakosyan Arcturus Therapeutics (NASDAQ:ARCT) shares surged 30% today following the company's reported {{erl-40973||Q4 results, with revenue coming in at $160.3 million, compared...
A Goldman Sachs analyst maintained Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) at Sell and a price target of $12.00 from a prior price target of $14.00. Prior to this rating,...
Investing.com - Arcturus Therapeutics Holdings Inc reported on Wednesday third quarter {{erl-40973||earnings that beat analysts' forecasts and revenue that topped expectations. Arcturus...
Arcturus Therapeutics (ARCT) reported Q3 EPS of ($1.33), $0.48 better than the analyst estimate of ($1.81). Revenue for the quarter came in at $13.4 million versus the consensus estimate of...
Arcturus Therapeutics (NASDAQ:ARCT) reported Q1 EPS of $1.94, $3.38 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $5.24 million versus the consensus...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Oil & Gas, Healthcare and Basic Materials sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Industrials, Oil & Gas and Technology sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Telecoms, Oil & Gas and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Oil & Gas, Financials and Basic Materials sectors propelled shares higher while losses in the Technology,...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Financials, Industrials and Telecoms sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Healthcare, Financials and Industrials sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Oil & Gas, Utilities and Consumer Goods sectors propelled shares lower. At the close in NYSE, the Dow...
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Financials, Industrials and Healthcare sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Healthcare, Utilities and Financials sectors propelled shares lower. At the close in NYSE, the Dow Jones...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
